Acute upper gastrointestinal bleeding (UGIB) is commonly encountered in emergency departments. Despite remarkable advancements in medical treatments and endoscopic interventions, it remains a potentially life-threatening event. The mortality rate among patients with acute UGIB can range from 2 to 15% [1, 2, 3]. This disease also presents with high morbidity, being one of the leading causes of hospitalization due to digestive disorders [4], and remains a significant and rising economic burden [5].
展开▼
